MeCP2 modulates gene expression pathways in astrocytes
Open accessThe DOI matches its Crossref record; 59 of the 61 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Mutations in MECP2 encoding methyl-CpG-binding protein 2 (MeCP2) cause the X-linked neurodevelopmental disorder Rett syndrome. Rett syndrome patients exhibit neurological symptoms that include irregular breathing, impaired mobility, stereotypic hand movements, and loss of speech. MeCP2 protein epigenetically modulates gene expression through genome-wide binding to methylated CpG dinucleotides. While neurons have the highest level of MeCP2 expression, astrocytes and other cell types also express detectable levels of MeCP2. Recent studies suggest that astrocytes likely control the progression of Rett syndrome. Thus, the object of these studies was to identify gene targets that are affected by loss of MeCP2 binding in astrocytes. METHODS: To identify gene targets of MeCP2 in astrocytes, combined approaches of expression microarray and chromatin immunoprecipitation of MeCP2 followed by sequencing (ChIP-seq) were compared between wild-type and MeCP2-deficient astrocytes. MeCP2 gene targets were compared with genes in the top 10% of MeCP2 binding levels in gene windows either within 2 kb upstream of the transcription start site, or the 'gene body' that extended from transcription start to end site, or 2 kb downstream of the transcription end site. RESULTS: A total of 118 gene transcripts surpassed the highly significant threshold (P < 0.005, fold change > 1.2) in expression microarray analysis from triplicate cultures. The top 10% of genes with the highest levels of MeCP2 binding were identified in two independent ChIP-seq experiments. Together this integrated, genome-wide screen for MeCP2 target genes provided an overlapping list of 19 high-confidence MeCP2-responsive gene transcripts in astrocytes. Validation of candidate target gene transcripts by RT-PCR revealed that expression of Apoc2, Cdon, Csrp and Nrep were consistently responsive to MeCP2 deficiency in astrocytes. CONCLUSIONS: The first MeCP2 ChIP-seq and gene expression microarray analysis in astrocytes reveals a set of potential MeCP2 target genes that may contribute to normal astrocyte signaling, cell division and neuronal support functions, the loss of which may contribute to the Rett syndrome phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MeCP2 is also essential for the functions of astrocytes and microglia (176, 177).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [176]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386 · cited 1×
“MeCP2 ChIP-seq data was first analyzed using established ChIP-seq algorithms including Sole-Search [33] ChromaSig [34] and MACS [35].”
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327 · cited 1×
“gov) [31,32].”
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990 · cited 1×
“Mutations in X-linked MECP2 encoding methyl-CpG-binding protein 2 (MeCP2) are responsible for most cases of RTT [3], although mutations in CDKL5 and FOXG1 were recently identified in MECP2 mutation-negative individuals with RTT features [4-6].”
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129 · cited 1×
“Additional dysregulated transcripts that have previously shown to have enriched expression in astrocytes [36] were identified in this screen include Ide encoding insulin-degrading enzyme, Gabrg1 encoding GABAA receptor gamma 1, and Egr1 encoding early growth response 1 protein.”
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,730 · cited 1×
“MeCP2 is one member of a family of DNA-binding proteins that was originally hypothesized to silence gene transcription by binding to methylated CpG dinucleotides in promoters [7].”
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-9-r60 · Cited by 2,376
Identifying biological themes within lists of genes with EASE
Hosack, D. A., Dennis, G., Sherman, B. T., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-10-r70 · Cited by 1,950 · cited 1×
“gov) [31,32].”
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. (2008) · Science · doi:10.1126/science.1153252 · Cited by 1,823 · cited 5×
“Subsequent genome-wide expression analyses of hypothalamus indicate that MeCP2 primarily activates but can also represses transcription [10].”
InfluentialIdentifying differentially expressed genes using false discovery rate controlling procedures
Reiner, A., Yekutieli, D., & Benjamini, Y. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btf877 · Cited by 1,765 · cited 1×
“…and wild-type controls, a Student ’ s unpaired t test with Benjamin-Hochberg false discovery rate (FDR) control (0.05) or no FDR control was conducted based on the two prefiltered gene lists generated under the MAS5 algorithm to identify upregulated genes and downregulated genes, respectively [30].”
InfluentialA Model-Based Background Adjustment for Oligonucleotide Expression Arrays
Wu, Z., Irizarry, R. A., Gentleman, R., Martinez-Murillo, F., & Spencer, F. (2004) · Journal of the American Statistical Association · doi:10.1198/016214504000000683 · Cited by 1,716 · cited 1×
“The GCRMA algorithm involves background correction, quartile normalization, summarization of the probe-set value into gene-level expression measurements [29].”
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
Guy, J., Hendrich, B., Holmes, M., Martin, J. E., & Bird, A. (2001) · Nature Genetics · doi:10.1038/85899 · Cited by 1,558 · cited 3×
“[17] were obtained from The Jackson Laboratory, Bar Harbor, ME, USA.”
Hagberg, B., Aicardi, J., Dias, K., & Ramos, O. (1983) · Annals of Neurology · doi:10.1002/ana.410140412 · Cited by 1,514 · cited 1×
“Clinical features include deceleration of brain growth, loss of motor skills including purposeful hand movements, absence of speech, seizures, and respiratory irregularity [2].”
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
Chen, R. Z., Akbarian, S., Tudor, M., & Jaenisch, R. (2001) · Nature Genetics · doi:10.1038/85906 · Cited by 1,275 · cited 1×
“As the symptoms of RTT syndrome are primarily neurological, MeCP2 function was originally hypothesized to be restricted to neurons [17,18].”
The Story of Rett Syndrome: From Clinic to Neurobiology
Chahrour, M., & Zoghbi, H. Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.10.001 · Cited by 1,265 · cited 1×
“RTT infants develop normally until six to eighteen months of age but then develop progressive loss of neurodevelopmental milestones [1].”
Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., & Greenberg, M. E. (2003) · Science · doi:10.1126/science.1086446 · Cited by 1,232 · cited 3×
“It appears that MeCP2 binding to DNA and subsequent transcriptional modulation is a dynamic process and dependent on external signals such as Ca 2+ [19,20].”
Briscoe, J., Pierani, A., Jessell, T. M., & Ericson, J. (2000) · Cell · doi:10.1016/s0092-8674(00)80853-3 · Cited by 1,112
Zhou, Z., Hong, E. J., Cohen, S., Zhao, W.-N., Ho, H.-Y. H., Schmidt, L., Chen, W. G., Lin, Y., Savner, E., Griffith, E. C., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.037 · Cited by 877 · cited 3×
“It appears that MeCP2 binding to DNA and subsequent transcriptional modulation is a dynamic process and dependent on external signals such as Ca 2+ [19,20].”
Neuronal MeCP2 Is Expressed at Near Histone-Octamer Levels and Globally Alters the Chromatin State
Skene, P. J., Illingworth, R. S., Webb, S., Kerr, A. R. W., James, K. D., Turner, D. J., Andrews, R., & Bird, A. P. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.030 · Cited by 688 · cited 4×
“Although MeCP2 levels are roughly five-fold lower in astrocytes than in neurons [11,21], recent studies suggest that loss of MeCP2 in astrocytes contributes to Rett-like symptoms and restoration of MeCP2 can rescue some of these defects [22].”
InfluentialWild-type microglia arrest pathology in a mouse model of Rett syndrome
Derecki, N. C., Cronk, J. C., Lu, Z., Xu, E., Abbott, S. B. G., Guyenet, P. G., & Kipnis, J. (2012) · Nature · doi:10.1038/nature10907 · Cited by 607 · cited 1×
“This is consistent with recent studies showing a key role for glia immune effector pathways in a mouse model of Rett syndrome [52].”
Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice
Tropea, D., Giacometti, E., Wilson, N. R., Beard, C., McCurry, C., Fu, D. D., Flannery, R., Jaenisch, R., & Sur, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812394106 · Cited by 593 · cited 1×
“This finding is consistent with reports of insulin pathway defects in Rett syndrome [54] [55].”
Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome
Horike, S.-I., Cai, S., Miyano, M., Cheng, J.-F., & Kohwi-Shigematsu, T. (2005) · Nature Genetics · doi:10.1038/ng1491 · Cited by 585 · cited 1×
“MeCP2 has also been shown to act as a chromatin organizer both in vivo [13,14] and in vitro [15].”
Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family
Mackenzie, B., & Erickson, J. D. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1117-9 · Cited by 515 · cited 1×
“…of glutamine the plasma membrane and an important player in the glutamine-glutamate/GABA cycle for neurotransmitter generation and cycling [38], although the functional role of astrocytic glutamine transporters have been less frequently studied compared to their neuronal counter-parts…”
Integrative analysis of the cancer transcriptome
Rhodes, D. R., & Chinnaiyan, A. M. (2005) · Nature Genetics · doi:10.1038/ng1570 · Cited by 498
A role for glia in the progression of Rett’s syndrome
Lioy, D. T., Garg, S. K., Monaghan, C. E., Raber, J., Foust, K. D., Kaspar, B. K., Hirrlinger, P. G., Kirchhoff, F., Bissonnette, J. M., Ballas, N., et al. (2011) · Nature · doi:10.1038/nature10214 · Cited by 496 · cited 2×
“Although MeCP2 levels are roughly five-fold lower in astrocytes than in neurons [11,21], recent studies suggest that loss of MeCP2 in astrocytes contributes to Rett-like symptoms and restoration of MeCP2 can rescue some of these defects [22].”
Young, J. I., Hong, E. P., Castle, J. C., Crespo-Barreto, J., Bowman, A. B., Rose, M. F., Kang, D., Richman, R., Johnson, J. M., Berget, S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507856102 · Cited by 484 · cited 1×
“In addition, MeCP2 appears to have a role in the regulation of splicing [16].”
Non–cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology
Ballas, N., Lioy, D. T., Grunseich, C., & Mandel, G. (2009) · Nature Neuroscience · doi:10.1038/nn.2275 · Cited by 466 · cited 1×
“This may potentially contribute to observed glial defects in Mecp2-deficient mice [21,43].”
FOXG1 Is Responsible for the Congenital Variant of Rett Syndrome
Ariani, F., Hayek, G., Rondinella, D., Artuso, R., Mencarelli, M. A., Spanhol-Rosseto, A., Pollazzon, M., Buoni, S., Spiga, O., Ricciardi, S., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.05.015 · Cited by 432 · cited 1×
“Mutations in X-linked MECP2 encoding methyl-CpG-binding protein 2 (MeCP2) are responsible for most cases of RTT [3], although mutations in CDKL5 and FOXG1 were recently identified in MECP2 mutation-negative individuals with RTT features [4-6].”
Yasui, D. H., Peddada, S., Bieda, M. C., Vallero, R. O., Hogart, A., Nagarajan, R. P., Thatcher, K. N., Farnham, P. J., & LaSalle, J. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707442104 · Cited by 381 · cited 4×
“[9]).”
InfluentialSelf-citationTudor, M., Akbarian, S., Chen, R. Z., & Jaenisch, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242566899 · Cited by 347 · cited 3×
“However, the list of identified MeCP2 target genes across different tissues and cell types and even different studies is tremendously variable with essentially non-overlapping gene lists [8,10,23-27].”
Immune signalling in neural development, synaptic plasticity and disease
Boulanger, L. M., & Shatz, C. J. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1428 · Cited by 334 · cited 1×
“Also there is emerging evidence that factors with immune function also have neurologic function in the immune system [53].”
Mari, F., Azimonti, S., Bertani, I., Bolognese, F., Colombo, E., Caselli, R., Scala, E., Longo, I., Grosso, S., Pescucci, C., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi198 · Cited by 318 · cited 1×
“Mutations in X-linked MECP2 encoding methyl-CpG-binding protein 2 (MeCP2) are responsible for most cases of RTT [3], although mutations in CDKL5 and FOXG1 were recently identified in MECP2 mutation-negative individuals with RTT features [4-6].”
Cohen, S., Gabel, H. W., Hemberg, M., Hutchinson, A. N., Sadacca, L. A., Ebert, D. H., Harmin, D. A., Greenberg, R. S., Verdine, V. K., Zhou, Z., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.022 · Cited by 298 · cited 1×
“More recent analyses of MeCP2 binding by ChIP-sequencing (ChIP-seq) have shown binding at near-histone occupancy levels throughout the neuronal genome [11,12].”
Rett Syndrome Astrocytes Are Abnormal and Spread MeCP2 Deficiency through Gap Junctions
Maezawa, I., Swanberg, S., Harvey, D., LaSalle, J. M., & Jin, L.-W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0324-09.2009 · Cited by 285 · cited 4×
“Although MeCP2 levels are roughly five-fold lower in astrocytes than in neurons [11,21], recent studies suggest that loss of MeCP2 in astrocytes contributes to Rett-like symptoms and restoration of MeCP2 can rescue some of these defects [22].”
InfluentialSelf-citationIdentifying biological themes within lists of genes with EASE
Hosack, D. A., Dennis, G., Sherman, B. T., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-6-p4 · Cited by 272
Jay, P., Rougeulle, C., Massacrier, A., Moncla, A., Mattel, M.-G., Malzac, P., Roëckel, N., Taviaux, S., Bergé Lefranc, J.-L., Cau, P., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-357 · Cited by 245 · cited 1×
“Another novel, astrocytic MeCP2 target gene was maternally imprinted Ndn. Ndn encodes Necdin, a growth-suppressing transcription factor, which may be deficient in the rare neurological disorder Prader-Willi syndrome [41].”
CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms
Scala, E., Ariani, F., Mari, F., Caselli, R., Pescucci, C., Longo, I., Meloni, I., Giachino, D., Bruttini, M., Hayek, G., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.026237 · Cited by 241 · cited 1×
“; licensee BioMed Central L Commons Attribution License (http://creativec reproduction in any medium, provided the or methyl-CpG-binding protein 2 (MeCP2) are responsible for most cases of RTT [3], although mutations in CDKL5 and FOXG1 were recently identified in MECP2 mutationnegative individuals with RTT features [4…”
Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome
Kriaucionis, S., Paterson, A., Curtis, J., Guy, J., MacLeod, N., & Bird, A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01665-05 · Cited by 219 · cited 1×
“However, the list of identified MeCP2 target genes across different tissues and cell types and even different studies is tremendously variable with essentially non-overlapping gene lists [8,10,23-27].”
Gliotransmission and the Tripartite Synapse
Santello, M., Calì, C., & Bezzi, P. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-7091-0932-8_14 · Cited by 214 · cited 1×
“Other affected genes like Cntn1 (Contactin 1), Syn2 (Synapsin 2), Gabrg1, and Gria1 function at the synapse where astrocytes make key functional crosstalk with neurons in a structural unit called a tripartite synapse [51].”
ChromaSig: A Probabilistic Approach to Finding Common Chromatin Signatures in the Human Genome
Hon, G. C., Ren, B., & Wang, W. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000201 · Cited by 163 · cited 1×
“MeCP2 ChIP-seq data was first analyzed using established ChIP-seq algorithms including Sole-Search [33] ChromaSig [34] and MACS [35].”
Bae, G., Domené, S., Roessler, E., Schachter, K. A., Kang, J., Muenke, M., & Krauss, R. S. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.07.001 · Cited by 145 · cited 1×
“Defects in Cdon expression cause a severe structural defect in the developing brain [47].”
Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets
Jordan, C., Li, H. H., Kwan, H. C. K., & Francke, U. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-36 · Cited by 144 · cited 2×
“Previous expression microarray analyses have focused on identifying MeCP2 target genes in brain [8,10, , 26,27] or cell lines [23,24,37] but not in individual cell types while MeCP2 ChIP-seq has been performed on sorted neuronal populations and astrocytes [11] but not in combination with expression…”
hZimp10 is an androgen receptor co‐activator and forms a complex with SUMO‐1 at replication foci
Sharma, M., Li, X., Wang, Y., Zarnegar, M. A., Huang, C., Palvimo, J. J., Lim, B., & Sun, Z. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg585 · Cited by 142 · cited 1×
“Despite ubiquitous expression, Zmiz1, can potentiate the activity of the androgen receptor [49] and thereby affect a number of AR-responsive genes, including those in brain.”
Maezawa, I., Nivison, M. P., Montine, K. S., Maeda, N., & Montine, T. J. (2006) · The FASEB Journal · doi:10.1096/fj.05-5423fje · Cited by 126 · cited 1×
“Primary astrocyte cultures were prepared from postnatal day 1 (P1) mouse cerebral cortex according to previously described methods [28] for expression profiling and MeCP2 ChIP-seq.”
Self-citationTv, N., Ghosh, R. P., Horowitz-Scherer, R. A., Hansen, J. C., Grigoryev, S. A., & Woodcock, C. L. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704304200 · Cited by 123 · cited 1×
“MeCP2 has also been shown to act as a chromatin organizer both in vivo [13,14] and in vitro [15].”
Blahnik, K. R., Dou, L., O'Geen, H., McPhillips, T., Xu, X., Cao, A. R., Iyengar, S., Nicolet, C. M., Ludäscher, B., Korf, I., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1012 · Cited by 118 · cited 1×
“MeCP2 ChIP-seq data was first analyzed using established ChIP-seq algorithms including Sole-Search [33] ChromaSig [34] and MACS [35].”
Peddada, S., Yasui, D. H., & LaSalle, J. M. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl124 · Cited by 112 · cited 2×
“Previous expression microarray analyses have focused on identifying MeCP2 target genes in brain [8,10, , 26,27] or cell lines [23,24,37] but not in individual cell types while MeCP2 ChIP-seq has been performed on sorted neuronal populations and astrocytes [11] but not in combination with expression…”
Self-citationYasui, D. H., Scoles, H. A., Horike, S., Meguro‐Horike, M., Dunaway, K. W., Schroeder, D. I., & LaSalle, J. M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr357 · Cited by 111 · cited 2×
“MeCP2 has also been shown to act as a chromatin organizer both in vivo [13,14] and in vitro [15].”
Self-citationMatsumoto, H., Nagasaka, T., Hattori, A., Rogi, T., Tsuruoka, N., Mizutani, S., & Tsujimoto, M. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02221.x · Cited by 108 · cited 1×
“Another target, Lnpep , encodes an insulin-regulated aminopeptidase, cleaves peptide hormones and may be involved in processing neuropeptides in the brain [44,45].”
Traynor, J., Agarwal, P., Lazzeroni, L. C., & Francke, U. (2002) · BMC Medical Genetics · doi:10.1186/1471-2350-3-12 · Cited by 105 · cited 2×
“However, the list of identified MeCP2 target genes across different tissues and cell types and even different studies is tremendously variable with essentially non-overlapping gene lists [8,10,23-27].”
Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism
Swanberg, S. E., Nagarajan, R. P., Peddada, S., Yasui, D. H., & LaSalle, J. M. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn380 · Cited by 105 · cited 1×
“Egr1, which was found to be a target of MeCP2 in neuronal cells [50], was tested but could not be validated by qRT-PCR for technical reasons.”
Self-citationGibson, J. H., Slobedman, B., KN, H., Williamson, S. L., Minchenko, D., El-Osta, A., Stern, J. L., & Christodoulou, J. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-53 · Cited by 100 · cited 2×
“However, the list of identified MeCP2 target genes across different tissues and cell types and even different studies is tremendously variable with essentially non-overlapping gene lists [8,10,23-27].”
Itoh, M., Ide, S., Takashima, S., Kudo, S., Nomura, Y., Segawa, M., Kubota, T., Mori, H., Tanaka, S., Horie, H., et al. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3180302078 · Cited by 93 · cited 1×
“This finding is consistent with reports of insulin pathway defects in Rett syndrome [54] [55].”
Melone, M. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh018 · Cited by 70 · cited 1×
“…of glutamine the plasma membrane and an important player in the glutamine-glutamate/GABA cycle for neurotransmitter generation and cycling [38], although the functional role of astrocytic glutamine transporters have been less frequently studied compared to their neuronal counter-parts [39].”
Regulation of Glioma Cell Migration by Seri ne-Phosphorylated P3111
McDonough, W. S., Tran, N. L., & Berens, M. E. (2005) · Neoplasia · doi:10.1593/neo.05190 · Cited by 64 · cited 1×
“Nrep, which has reduced transcripts in MeCP2 null astrocytes, is an important factor involved in glial mobility and neoplasia [42].”
Expression profiling of clonal lymphocyte cell cultures from Rett syndrome patients
Delgado, I. J., Kim, D. S., Thatcher, K. N., LaSalle, J. M., & den Veyver, I. B. V. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-61 · Cited by 40 · cited 1×
“Previous expression microarray analyses have focused on identifying MeCP2 target genes in brain [8,10, , 26,27] or cell lines [23,24,37] but not in individual cell types while MeCP2 ChIP-seq has been performed on sorted neuronal populations and astrocytes [11] but not in combination with expression…”
Self-citationCysteine‐ and glycine‐rich protein 1a is involved in spinal cord regeneration in adult zebrafish
Ma, L., Yu, Y., Guo, Y., Hart, R. P., & Schachner, M. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07958.x · Cited by 28 · cited 1×
“Csrp1 , which has elevated astrocytic expression in the absence of MeCP2, appears to have a role in neuronal regeneration [46].”
Brain Lipid Analysis in Mice with Rett Syndrome
Seyfried, T. N., Heinecke, K. A., Mantis, J. G., & Denny, C. A. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9874-7 · Cited by 15 · cited 1×
“Although lipid abnormalities have not been reported, defects in the MeCP2 astrocyte target Apoc2 may contribute to cardiac defects reported in Rett model mice [48].”
Kitamura, M., Itoh, K., Matsumoto, A., Hayashi, Y., Sasaki, R., Imai, Y., & Itoh, H. (2001) · PubMed · doi:10.24546/00062727 · Cited by 15
Matsumoto, A., Motozaki, K., Seki, T., Sasaki, R., & Kawabe, T. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(00)00229-7 · Cited by 11 · cited 1×
“Another target, Lnpep , encodes an insulin-regulated aminopeptidase, cleaves peptide hormones and may be involved in processing neuropeptides in the brain [44,45].”
Cited by
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders
Sahin, M., & Sur, M. (2015) · Science · doi:10.1126/science.aab3897 · Cited by 295
“ASD genes such as Fmr1 and Mecp2 are now known to influence astrocyte function (99).”
BackgroundHuman astrocytes in the diseased brain
Dossi, E., Vasile, F., & Rouach, N. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.02.001 · Cited by 250
Mechanisms of astrocyte development and their contributions to neurodevelopmental disorders
Sloan, S. A., & Barres, B. A. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.03.005 · Cited by 252
“Now, ChIP-seq and gene expression analyses of MECP2 / astrocytes are beginning to identify aberrantly expressed target genes that may play a direct role in astrocyte-mediated disease pathogenesis [49].”
Cronk, J. C., Derecki, N. C., Ji, E., Xu, Y., Lampano, A. E., Smirnov, I., Baker, W., Norris, G. T., Marin, I., Coddington, N., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.013 · Cited by 199
“Recent reports have found expression and roles for Mecp2 in astrocytes (Ballas et al., 2009; Lioy et al., 2011; Yasui et al., 2013), oligodendrocytes (Nguyen et al., 2013), and microglia (Derecki et al., 2012; Maezawa and Jin, 2010).”
Background
Metadata
- Authors
- Yasui, D. H., Xu, H., Dunaway, K. W., LaSalle, J. M., Jin, L.-W., & Maezawa, I.
- Affiliations
- University of California, Davis (US)
- National Institutes of Health (US)
- University of California Davis Medical Center (US)
- Corresponding author
- Yasui, Dag H
- Venue
- Molecular Autism
- Published
- 2013
- Volume
- 4
- Issue
- 1
- Pages
- 3
- ISSN
- 2040-2392 (ISSN-L)
- PMC
- PMC3561260
- OpenAlex
- W2151149439
- Cited by
- 90
- References
- 61
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 3 · 2022: 6 · 2021: 7 · 2020: 4 · 2019: 10 · 2018: 7 · 2017: 7 · 2016: 11 · 2015: 13 · 2014: 9 · 2013: 2
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Molecular Autism (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (P30CA093373)
- National Institute of Neurological Disorders and Stroke (R01NS076263, R01NS081913)
- National Institute of Environmental Health Sciences (T32ES007059)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD064817)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- MeCP2, Rett syndrome, astrocytes, epigenetic regulation, gene expression profiling, ChIP-seq, APOC2, CDON, X-linked neurodevelopmental disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.